United States · FDA National Drug Code directory
Vizamyl
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 17156-067_4fda8ebc-b46e-4d12-9c45-8cbb3a2516bb
- Product NDC
- 17156-067
- Form
- SOLUTION
- Composition / generic term
- Flutemetamol F-18
- Labeler
- GE Healthcare Inc. (Medi-Physics, Inc. dba GE Healthcare)
- Marketing category
- NDA
- Marketing start / end (source format)
- 20140101
- Source listing expiry
- 20271231
Source-listed ingredients
- FLUTEMETAMOL F-18 — 4.05 mCi/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, MULTI-DOSE in 1 CONTAINER (17156-067-30) / 30 mL in 1 VIAL, MULTI-DOSE · 17156-067-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →